Bryan Irving
Impact in
- Immunology top 0.2%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
- Immune cells in cancer
- Oncology top 0.5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
- Oncology 27
- CAR-T cell therapy research 17
- Cancer Immunotherapy and Biomarkers 13
- Immunology 24
- Immunotherapy and Immune Responses 13
- Immune Cell Function and Interaction 13
- T-cell and B-cell Immunology 12
- Co-authors
- Arthur Weiss (11 shared papers)Andrew C. Chan (6 shared papers)James D. Fraser (2 shared papers)Jane L. Grogan (3 shared papers)Xin Yu (2 shared papers)Dan Eaton (2 shared papers)F. Stephen Hodi (3 shared papers)Daniel S. Chen (3 shared papers)
- Journals
- Cancer Research (10 papers)Science (3 papers)Molecular Cancer Therapeutics (3 papers)Cell (2 papers)Proceedings of the National Academy of Sciences (2 papers)
- Partner nations
- United StatesFranceSwitzerland
In The Last Decade
Bryan Irving
44 papers receiving 7.8k citations
Bryan Irving's Hit Papers
Peers
Comparison fields: 5 of 106
- Immunology 5.2k
- Oncology 3.8k
- Immunology and Allergy 363
- Radiology, Nuclear Medicine and Imaging 883
- Virology 155
Countries citing papers authored by Bryan Irving
This map shows the geographic impact of Bryan Irving's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bryan Irving with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bryan Irving more than expected).
Fields of papers citing papers by Bryan Irving
This network shows the impact of papers produced by Bryan Irving. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bryan Irving. The network helps show where Bryan Irving may publish in the future.
Co-authors
The 25 scholars most cited alongside Bryan Irving, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells Hit paper breakdown → | 2008 | 1142 |
| 2 | The Immunoreceptor TIGIT Regulates Antitumor and Antiviral CD8 + T Cell Effector Function Hit paper breakdown → | 2014 | 910 |
| 3 | The cytoplasmic domain of the T cell receptor ζ chain is sufficient to couple to receptor-associated signal transduction pathways Hit paper breakdown → | 1991 | 702 |
| 4 | Sequential Interactions of the TCR with Two Distinct Cytoplasmic Tyrosine Kinases Hit paper breakdown → | 1994 | 624 |
| 5 | Regulation of Interleukin-2 Gene Enhancer Activity by the T Cell Accessory Molecule CD28 Hit paper breakdown → | 1991 | 560 |
| 6 | Interaction of the unique N-terminal region of tyrosine kinase p56lck with cytoplasmic domains of CD4 and CD8 is mediated by cysteine motifs Hit paper breakdown → | 1990 | 553 |
| 7 | MAP Kinase Inhibition Promotes T Cell and Anti-tumor Activity in Combination with PD-L1 Checkpoint Blockade Hit paper breakdown → | 2016 | 536 |
| 8 | Molecular Pathways: Next-Generation Immunotherapy—Inhibiting Programmed Death-Ligand 1 and Programmed Death-1 Hit paper breakdown → | 2012 | 500 |
| 9 | Bruton Tyrosine Kinase–Dependent Immune Cell Cross-talk Drives Pancreas Cancer Hit paper breakdown → | 2015 | 386 |
| 10 | 1991 | 367 | |
| 11 | 2018 | 330 | |
| 12 | 1993 | 289 | |
| 13 | 2017 | 273 | |
| 14 | 2014 | 232 | |
| 15 | 1998 | 153 | |
| 16 | 2023 | 60 | |
| 17 | 2013 | 51 | |
| 18 | 2022 | 41 | |
| 19 | 1998 | 26 | |
| 20 | 2018 | 25 |
About Bryan Irving
Bryan Irving is a scholar working on Oncology, Immunology, Radiology, Nuclear Medicine and Imaging, Molecular Biology and Biotechnology, having authored 44 papers that have together received 7.9k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (23 papers), CAR-T cell therapy research (17 papers), Immunotherapy and Immune Responses (13 papers), Cancer Immunotherapy and Biomarkers (13 papers), Immune Cell Function and Interaction (13 papers), T-cell and B-cell Immunology (12 papers), Glycosylation and Glycoproteins Research (6 papers) and Cancer Research and Treatments (3 papers). The work is most often cited by research in Immunology (5.2k citations), Oncology (3.8k citations), Immunology and Allergy (363 citations), Radiology, Nuclear Medicine and Imaging (883 citations) and Virology (155 citations). Bryan Irving has collaborated with scholars based in United States, France and Switzerland. Frequent co-authors include Arthur Weiss, Andrew C. Chan, James D. Fraser, Jane L. Grogan, Xin Yu, Dan Eaton, F. Stephen Hodi, Daniel S. Chen, Gerald R. Crabtree and Nicolai S. C. van Oers. Their work appears in journals such as Cancer Research, Science, Molecular Cancer Therapeutics, Cell and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.